In standard clinical practice, a patient’s dry weight or target weight is an estimate which is determined by the clinical observation of various indications, including the presence of oedema, the blood pressure values and shortness of breath. The frequent occurrence of comorbidities in hemodialysis patients can make the signs of fluid status ambiguous, however.1
The BCM - Body Composition Monitor was specifically designed to determine the amount of fluid overload that arises in patients suffering from renal failure. This allows for a simple, non-invasive and objective assessment of an individual patient’s fluid status.2
As a result, the BCM - Body Composition Monitor may help the clinician to determine a patient’s individual dry weight more accurately and, as a result, to remove the correct amount of fluid.
The BCM - Body Composition Monitor allows for the practical and accurate determination of the fluid status in contrast to alternative assessment methods.3
Assessing the fluid status with the BCM - Body Composition Monitor:
The technology behind the BCM - Body Composition Monitor
The BCM - Body Composition Monitor applies the Bioimpedance Spectroscopy (BIS) technique.
To obtain the clinically-relevant output parameters, two advanced validated physiological models are used in the BCM - Body Composition Monitor:
Especially validated for ESRD patients | Suitable for HD & PD patients | Over 29,000 patients measured* | Appropriate for pediatric patients |
---|
* in NephroCare clinics each month in 201517
[Translate to English (MEA):] BCM - Body Composition Monitor Technical data
PDF, 1 MB